Lead author Professor Sunil Badve, professorial fellow at The George Institute for Global Health and UNSW Sydney, said the study expanded current knowledge about the drugs in key areas, including benefits in people with chronic kidney disease (CKD), and in people with and without diabetes
Crowson AN, Magro CM, Mihm Jr MC
[DOI] [PubMed] [Google Scholar] Avshalumov MV, Rice ME
doi: 10.2337/db12-0797 67 CeglaJTrokeRCJonesBTharakanGKenkreJMcCulloughKAet al
In the United States, compounded drugs are not FDA-approved
These are licensed prescription-only medicines approved by the MHRA and the European Medicines Agency (EMA) specifically for weight management in defined patient groups (see NICE TA875 for semaglutide and NICE TA664 for liraglutide)